**Meet the editor**

Mojca Božič Mijovski is currently the head of Laboratory for Haemostasis and Atherothrombosis at the University Medical Centre Ljubljana, Slovenia, and assistant professor in Haemostasis at the University of Ljubljana, Faculty of Pharmacy. She received her PhD in Biochemistry and Molecular Biology at the Medical Faculty (University of Ljubljana) and a specialist degree in

Medical Biochemistry at the Slovenian Ministry of Health. She is a member of the Scientific Board of the European and Mediterranean League against Thrombotic Diseases, a member of the International Society of Thrombosis and Haemostasis and the president of the Commission for Continuous Education at the Slovene Chamber of Laboratory Medicine. Her research in the field of thrombosis and haemostasis has resulted in over 30 articles published in peer-reviewed journals.

Contents

**Preface VII**

**Clinical Practice 1**

Alvarez Flores

Nina Vene and Alenka Mavri

Chapter 3 **Anticoagulants from Hematophagous 39**

**Stage Kidney Disease 69**

Chapter 5 **Real-World Safety of Anticoagulants 83**

Chapter 6 **Heparin-Induced Thrombocytopenia (HIT) 101**

Chapter 2 **FXa Direct Synthetic Inhibitors 11** Flavia C. Zacconi

Chapter 1 **An Overview of the Anticoagulant Drugs Used in Routine**

Chapter 4 **Anticoagulation for Atrial Fibrillation in Patients with End-**

Quoc Tran, Bassim Jebeili, Kamal Sud and Bhadran Bose

Niccolò Lombardi, Giada Crescioli and Alfredo Vannacci

Maja Tomicic, Irena Jukic, Ana Hecimovic and Tomislav Vuk

Ana Marisa Chudzinski-Tavassi, Fernanda Faria and Miryam Paola
